Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17956668rdf:typepubmed:Citationlld:pubmed
pubmed-article:17956668lifeskim:mentionsumls-concept:C1704939lld:lifeskim
pubmed-article:17956668lifeskim:mentionsumls-concept:C0242643lld:lifeskim
pubmed-article:17956668lifeskim:mentionsumls-concept:C1517806lld:lifeskim
pubmed-article:17956668lifeskim:mentionsumls-concept:C0079904lld:lifeskim
pubmed-article:17956668lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:17956668lifeskim:mentionsumls-concept:C1555029lld:lifeskim
pubmed-article:17956668lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:17956668lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:17956668lifeskim:mentionsumls-concept:C1998811lld:lifeskim
pubmed-article:17956668pubmed:issue5lld:pubmed
pubmed-article:17956668pubmed:dateCreated2007-10-24lld:pubmed
pubmed-article:17956668pubmed:abstractTextThis study was purposed to investigate whether the mdr1 participates in antiapoptotic mechanisms of hematologic malignant cells regulated by NF-kappaB and to explore the reversal effect of inhibiting NF-kappaB on drug-resistance of hematologic malignant cells so as to search a novel way for treatment of refractory leukemia. NF-kappaB activity and P-gp expression in K562/A02 cells cultured with PDTC in different concentration or different time were detected by immunohistochemistry and computerized picture analysis. The mdr1 was detected by reverse transcription-polymerase chain reaction, and the relationship among NF-kappaB, P-gp and mdr1 was analyzed. The results showed that in K562/A02 cells the expression of P-gp and mdr1 were positively correlated with NF-kappaB/p65, which showed the concentration and time dependent manner. It is concluded the mechanism of NF-kappaB regulating anti-apoptosis in K562/A02 cells has the correlation with the expression of mdr1 and P-gp. The expression of mdr 1 mRNA and P-gp can be reduced through inhibiting NF-kappaB in K562/A02 cells, so that the sensitivity of chemical therapy can be enhanced on hematologic malignant cells.lld:pubmed
pubmed-article:17956668pubmed:languagechilld:pubmed
pubmed-article:17956668pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17956668pubmed:citationSubsetIMlld:pubmed
pubmed-article:17956668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17956668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17956668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17956668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17956668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17956668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17956668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17956668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17956668pubmed:statusMEDLINElld:pubmed
pubmed-article:17956668pubmed:monthOctlld:pubmed
pubmed-article:17956668pubmed:issn1009-2137lld:pubmed
pubmed-article:17956668pubmed:authorpubmed-author:SzeS HSHlld:pubmed
pubmed-article:17956668pubmed:authorpubmed-author:WangYiYlld:pubmed
pubmed-article:17956668pubmed:authorpubmed-author:YuMinMlld:pubmed
pubmed-article:17956668pubmed:authorpubmed-author:WangHuiHlld:pubmed
pubmed-article:17956668pubmed:authorpubmed-author:ZhangHai-TaoH...lld:pubmed
pubmed-article:17956668pubmed:issnTypePrintlld:pubmed
pubmed-article:17956668pubmed:volume15lld:pubmed
pubmed-article:17956668pubmed:ownerNLMlld:pubmed
pubmed-article:17956668pubmed:authorsCompleteYlld:pubmed
pubmed-article:17956668pubmed:pagination950-4lld:pubmed
pubmed-article:17956668pubmed:meshHeadingpubmed-meshheading:17956668...lld:pubmed
pubmed-article:17956668pubmed:meshHeadingpubmed-meshheading:17956668...lld:pubmed
pubmed-article:17956668pubmed:meshHeadingpubmed-meshheading:17956668...lld:pubmed
pubmed-article:17956668pubmed:meshHeadingpubmed-meshheading:17956668...lld:pubmed
pubmed-article:17956668pubmed:meshHeadingpubmed-meshheading:17956668...lld:pubmed
pubmed-article:17956668pubmed:meshHeadingpubmed-meshheading:17956668...lld:pubmed
pubmed-article:17956668pubmed:meshHeadingpubmed-meshheading:17956668...lld:pubmed
pubmed-article:17956668pubmed:meshHeadingpubmed-meshheading:17956668...lld:pubmed
pubmed-article:17956668pubmed:meshHeadingpubmed-meshheading:17956668...lld:pubmed
pubmed-article:17956668pubmed:meshHeadingpubmed-meshheading:17956668...lld:pubmed
pubmed-article:17956668pubmed:meshHeadingpubmed-meshheading:17956668...lld:pubmed
pubmed-article:17956668pubmed:year2007lld:pubmed
pubmed-article:17956668pubmed:articleTitle[NF-kappaB regulating expression of mdr1 gene and P-gp to reverse drug-resistance in leukemic cells].lld:pubmed
pubmed-article:17956668pubmed:affiliationDepartment of Hematology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710061, China.lld:pubmed
pubmed-article:17956668pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17956668pubmed:publicationTypeEnglish Abstractlld:pubmed
entrez-gene:5243entrezgene:pubmedpubmed-article:17956668lld:entrezgene
entrez-gene:5970entrezgene:pubmedpubmed-article:17956668lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17956668lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17956668lld:entrezgene